A. Widmer

2.6k total citations · 1 hit paper
14 papers, 1.3k citations indexed

About

A. Widmer is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, A. Widmer has authored 14 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Rheumatology, 6 papers in Immunology and 5 papers in Hematology. Recurrent topics in A. Widmer's work include Psoriasis: Treatment and Pathogenesis (6 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Spondyloarthritis Studies and Treatments (5 papers). A. Widmer is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (6 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Spondyloarthritis Studies and Treatments (5 papers). A. Widmer collaborates with scholars based in Switzerland, United States and Germany. A. Widmer's co-authors include Xavier Gitton, É. Hachulla, Kieron Leslie, Helen J. Lachmann, Philip N. Hawkins, Pierre Quartier, Jasmin Kuemmerle‐Deschner, Isabelle Koné‐Paut, Luminita Pricop and Brian Porter and has published in prestigious journals such as New England Journal of Medicine, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

A. Widmer

14 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome

2009 627 citations Helen J. Lachmann, Isabelle Koné‐Paut et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Widmer Switzerland	8	682	663	467	387	141	14	1.3k
Qiongyi Hu China	18	279 0.4×	402 0.6×	418 0.9×	302 0.8×	55 0.4×	57	843
Ayşe Çefle Türkiye	17	279 0.4×	267 0.4×	137 0.3×	492 1.3×	82 0.6×	94	1.0k
İzzet Fresko Türkiye	24	299 0.4×	208 0.3×	246 0.5×	1.0k 2.6×	40 0.3×	82	2.4k
Tuyet‐Hang Pham United States	14	305 0.4×	541 0.8×	185 0.4×	151 0.4×	38 0.3×	25	1.1k
A. Accardo-Palumbo Italy	15	139 0.2×	326 0.5×	232 0.5×	377 1.0×	61 0.4×	30	810
Noriyuki Hiramatsu Japan	9	256 0.4×	371 0.6×	77 0.2×	181 0.5×	242 1.7×	15	870
Simona Truglia Italy	20	209 0.3×	435 0.7×	252 0.5×	852 2.2×	100 0.7×	82	1.3k
Szilvia Szamosi Hungary	20	235 0.3×	286 0.4×	92 0.2×	386 1.0×	71 0.5×	58	1.0k
R. H. W. M. Derksen Netherlands	25	149 0.2×	619 0.9×	544 1.2×	1.3k 3.4×	239 1.7×	41	1.9k
Élisabeth Palazzo France	21	161 0.2×	213 0.3×	150 0.3×	939 2.4×	216 1.5×	51	1.4k

Countries citing papers authored by A. Widmer

Since Specialization

Citations

This map shows the geographic impact of A. Widmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Widmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Widmer more than expected).

Fields of papers citing papers by A. Widmer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Widmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Widmer. The network helps show where A. Widmer may publish in the future.

Co-authorship network of co-authors of A. Widmer

This figure shows the co-authorship network connecting the top 25 collaborators of A. Widmer. A scholar is included among the top collaborators of A. Widmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Widmer. A. Widmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Kivitz, Alan, Peter Nash, Hasan Tahir, et al.. (2019). Efficacy and Safety of Subcutaneous Secukinumab 150 mg with or Without Loading Regimen in Psoriatic Arthritis: Results from the FUTURE 4 Study. Rheumatology and Therapy. 6(3). 393–407. 61 indexed citations

McInnes, Iain B., Philip J. Mease, Kristian Reich, et al.. (2019). 257 Secukinumab demonstrates a consistent safety profile with up to 5 years’ treatment in patients with psoriatic arthritis and moderate-to-severe plaque psoriasis: updated pooled safety analyses. Lara D. Veeken. 58(Supplement_3). 1 indexed citations

Deodhar, Atul, Iain B. McInnes, Xenofon Baraliakos, et al.. (2019). Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data. Arthritis Research & Therapy. 21(1). 111–111. 215 indexed citations

Mease, Philip J., Iain B. McInnes, Kristian Reich, et al.. (2018). THU0325 Secukinumab demonstrates a consistent safety profile with up to 5 years treatment in patients with psoriatic arthritis and moderate to severe plaque psoriasis: updated pooled safety analyses. Annals of the Rheumatic Diseases. 77. 381–382. 3 indexed citations

Nash, Peter, Philip Mease, Iain B. McInnes, et al.. (2016). Secukinumab Safety and Tolerability in Patients with Active Psoriatic Arthritis and Psoriasis: Results From a Pooled Safety Analysis. Internal Medicine Journal. 46. 39–39. 2 indexed citations

Tłustochowicz, Witold, Proton Rahman, B. Seriolo, et al.. (2016). Efficacy and Safety of Subcutaneous and Intravenous Loading Dose Regimens of Secukinumab in Patients with Active Rheumatoid Arthritis: Results from a Randomized Phase II Study. The Journal of Rheumatology. 43(3). 495–503. 32 indexed citations

Mease, Philip J., Iain B. McInnes, H. Richards, et al.. (2015). SAT0579 Secukinumab Safety and Tolerability in Patients with Active Psoriatic Arthritis: Pooled Safety Analysis of Two Phase 3, Randomized, Controlled Trials (Future 1 and Future 2). Annals of the Rheumatic Diseases. 74. 870–871. 6 indexed citations

Alten, Rieke, Juan J. Gómez‐Reino, Patrick Durez, et al.. (2011). Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, phase II, dose-finding study. BMC Musculoskeletal Disorders. 12(1). 153–153. 114 indexed citations

Kuemmerle‐Deschner, J. B., É. Hachulla, Philip N. Hawkins, et al.. (2011). Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes. Annals of the Rheumatic Diseases. 70(12). 2095–2102. 154 indexed citations

10.

Lachmann, Helen J., Isabelle Koné‐Paut, Jasmin Kuemmerle‐Deschner, et al.. (2009). Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome. New England Journal of Medicine. 360(23). 2416–2425. 627 indexed citations breakdown →

11.

Reid, Ian R., Jacques P. Brown, P. Burckhardt, et al.. (2003). Intravenous Zoledronic Acid in Postmenopausal Women With Low Bone Mineral Density. Obstetrical & Gynecological Survey. 58(1). 33–35. 78 indexed citations

12.

Woggon, B., Jörg Fleischhauer, & A. Widmer. (1979). [Influence of diagnosis, hospital and sex on the effects of bromperidol].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 14(4). 213–27. 1 indexed citations

13.

Widmer, A., et al.. (1977). An experimental contribution to the question of the existence of lighting-like discharges in dust clouds. Journal of Electrostatics. 3(4). 303–310. 23 indexed citations

14.

Widmer, A., et al.. (1975). Experimente zur Frage nach blitzähnlichen Entladungen aufgeladener Staubwolken. Chemie Ingenieur Technik. 47(6). 251–252. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact